Tuesday, April 7, 2009

Trial Provides New Hope For Those Living With Irritable Bowel Syndrome

A unique health supplement could give fresh hope to those living with Irritable Bowel Syndrome (IBS) as trials reveal it can reduce symptoms of the chronic condition, affecting up to one in five of the UK population1. "Second generation" galactooligosaccharide Bimuno® was found to reduce abdominal pain and bloating, ease bowel movements and improve stool consistency in those diagnosed with IBS. More at...